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Maintaining genomic stability in the face of replication and recombination requires a huge variety of different damage
response proteins. A cell’s ability to decide when and where to deploy this DNA repair kit is critical to prevent tumor
development. This issue’s Select highlights recent studies that help to explain how these difficult decisions are made
and reveals that some surprising cellular locations impact genomic stability.HDAC inhibition stimulates autophagy. mCherry-Ape1 (red)
and GFP-Atg8 (green) reveal an autophagic vacuole formed
in the presence of the HDAC inhibitor valproic acid.Making DNA Repair Easier to Swallow
Histone deacetylases (HDACs) are known to have a broad range of
substrates that function in many different biological pathways. Rob-
ert etal. (2011)nowfind thatproteinacetylationprovidesapotentially
important link between the DNA-damage response and autophagy
in yeast. Using an HDAC inhibitor, they find that HDAC activity is
required for efficient DNA double-stranded break (DSB) repair. Part
of the reason for this sensitivity appears to be a dramatic reduction
in the expression level of the repair protein Sae2 upon HDAC inhibi-
tion. They show that two specific HDACs, Hda1 and Rpd3, are
required for deacetylation of Sae2, and that in the absence of these
HDACs, Sae2 is destabilized by acetylation. Unexpectedly, this
destabilization depends on autophagy—a process more commonly
associated with the clearance of large cytoplasmic structures such
asprotein aggregates andorganelles.Blocking autophagy stabilizes
Sae2, rescuing the DSB repair defect of HDAC mutant cells.
This intriguing result raises many questions about how and even
whyautophagyandDSBrepairarecoordinated.Theauthorspropose
that regulatory acetylation might ensure that potentially dangerous
repair activity is spatially restricted within the nucleus (possibly close
tonuclearpores,where themostseverelydamagedDNA is thought to
accumulate). However, it remains to be seen whether acetylation
specifically enhances the nuclear export of proteins such as Sae2,
or whether the impact of acetylation acts further downstream to
promote Sae2 targeting to the autophagic vacuole.
Robert, T., et al. (2011). Nature 471, 74–79.Silencing theDNA-damage response. The
DNA-damage sensor NBS1 (green) is
excluded from senescence-associated
heterochromatin (regionsof intenseblue).The Silence of Senescence
Another recent study uncovers an alternative, more drastic mechanism used by cells
to keep DNA-damage response (DDR) signaling under control. Activation of onco-
genes deregulates DNA replication and increases the formation of DSBs. This results
in sustained DDR activation, which is sufficient to drive cells into a protective, senes-
cent state that blocks further proliferation. Oncogene-induced senescence is accom-
panied by large-scale changes in chromatin organization, which were initially
proposed to act both locally to inhibit the expression of specific proliferative genes
and more globally to shunt larger portions of the genome into a silenced, heterochro-
matic state. Until now, the function of this senescence-associated heterochromatin
formation (SAHF) has been unclear. Di Micco et al. (2011) report that targeted gene
silencing and SAHF represent two distinctly regulated pathways in human cells,
with separable functions. Whereas local silencing depends on p53 and the ATM
kinase cascade, and is required to prevent proliferation, SAHF depends on ATR
kinase signaling and appears to specifically dampen the DNA-damage response.
What might the advantage be in downregulating this damage response in senes-
cent cells? The authors show that disrupting SAHF, by promoting histone acetylation
and chromatin decondensation, increases DDR signaling and leads to apoptosis,
both in oncogene-transformed human cultured epithelial cells and in mouse xeno-
grafts. SAHF might therefore act as a protective response to maintain senescent
cell viability. The physiological benefits conferred by this strategy are unclear. Senes-
cent cells are thought to play a non-cell-autonomous role by secreting immunemodu-
lators to recruit the innate immune response. Perhaps keeping senescent cells aliveCell 145, April 1, 2011 ª2011 Elsevier Inc. 5
represents a more effective means of tumor suppression than relying on cell-autonomous mechanisms to limit the growth of
transformed cells.
Di Micco, R., et al. (2011). Nat. Cell Biol. 13, 292–302.The aging heart. Mice lacking telomeres develop defects,
including thinning of the left ventricular wall, in quiescent
tissues such as the heart.Aging Telomeres Hit the Power Switch
Progressive loss of the telomeres protecting chromosome ends is
thought to be one of the major factors driving replicative senes-
cence and cellular aging. Consistent with this, telomerase-deficient
mice succumb to premature aging, characterized by functional
decline in multiple tissues. Interestingly, this decline is not limited
to organs with rapid cellular turnover, which experience classical
DNA-damage checkpoint responses such as senescence and
apoptosis, but also affects more quiescent tissues such as the
heart and liver, manifesting as heart failure and impaired metabo-
lism. How can telomere loss impair the function of such nonrepli-
cating cells?
A recent study now provides a possible explanation, revealing
that uncapped telomeres can repress key regulators of mitochon-
drial biogenesis and function. Mitochondrial functional decline is
a known hallmark of aging tissues and senescent cells in culture.Sahin et al. (2011) show that activation of the p53-dependent nuclear DNA-damage response by shortened telomeres impairs
mitochondrial function in telomerase-deficient mice. p53 acts to suppress the transcription of the mitochondrial regulators
Pgc1a and Pgc1b, leading to reduced mitochondrial DNA content and ATP synthesis. Strikingly, inhibition of p53 not only
restores mitochondrial DNA copy number but also is sufficient to partially rescue the defective gluconeogenesis and cardiac
function observed in telomerase-deficient mice. These findings therefore forge a direct molecular link between the telomeric
and mitochondrial theories of aging, paving the way for future work to establish the
relative contributions of nuclear DNA-damage checkpoint responses and mitochon-
drial decline in the aging of different tissues.
Sahin, E., et al. (2011). Nature 470, 359–365.When X meets Y. Mouse spermatocyte
chromosomes labeled with antibodies
against SYCP3 (red) and SYCP1 (green).
In the absence of Spo11a (lower panel),
X and Y chromosomes (red) fail to asso-
ciate and recombine.(X + Y)/2 = ?
Not all DNA damage is a sign of trouble ahead. The regulated formation of DSBs by
the Spo11 protein during meiosis, for example, is crucial for pairing and recombina-
tion between homologous chromosomes and thereby promotes accurate chromo-
some segregation and genetic diversity. However, male meiosis presents a particular
challenge for the cell: how to pair-up and accurately segregate the mostly nonhomol-
ogous X and Y chromosomes. Unlike their autosomal counterparts, X and Y cannot
depend on multiple contacts along the length of the chromosome to ensure stable
pairing. Instead, they rely upon a relatively small stretch of DNA, present on both
the X and Y chromosomes, called the pseudoautosomal region (PAR). Kauppi et al.
(2011) now shed light on the mysterious process of PAR pairing and recombination.
They find that XY pairing occurs late duringmeiosis, and PARDSBs form inmost cells
within a narrow time-window after the repair of autosomal DSBs has commenced.
The frequency of DSBswithin the PAR is significantly increased relative to that in other
regions of the genome. This fact may perhaps be explained by the authors’ observa-
tions that the region forms shorter, more frequent chromatin loops, potentially
increasing the accessibility of PAR DNA to Spo11.
Taken together, the findings suggest that PAR recombination likely depends on
a set of regulators distinct from that of other chromosomes. This conclusion is further
strengthened by genetic experiments that specifically ablate splice variants of Spo11.
Female mice lacking Spo11a (which appears relatively late in meiosis) but expressing
Spo11b apparently undergo normal levels of meiotic recombination, whereas male
mice of the same genotype fail to establish PAR DSBs and XY pairing in most cells.
Armed with this information, it should now be possible to dissect in further detail
the molecular mechanisms that ensure reliable segregation of sex chromosomes.
Kauppi, L., et al. (2011). Science 331, 916–920.
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